Primary Ovarian Insufficiency: A Case of the Cart before the Horse
DOI:
https://doi.org/10.62836/amr.v3i1.167Abstract
Overt Primary Ovarian Insufficiency (POI) is a rare disorder characterized by a constellation of other rare conditions, posing significant diagnostic and management challenges. This disorder necessitates a global mechanism for information exchange, streamlined data sharing, dynamic international partnerships, and the integration of artificial intelligence to enhance diagnostic accuracy through next-generation sequencing and specific antibody testing. Empowering women with POI involves providing them with access to the best available evidence at the point of care and facilitating informed decisions throughout their health journey. A key strategy is transcending the traditional biomedical model by adopting a population-based approach that encourages global cross-sectional collaboration. Optimal care for women with POI is achieved through an integrated, multidisciplinary approach that leverages diverse expertise to evaluate evidence and update care practices effectively. Initiatives are also underway to establish a patient advocacy group, emphasizing the importance of early diagnosis in allowing women to adapt family planning or preserve fertility. The overarching vision for POI research and care aims to cultivate proactive international partnerships and data sharing, driven by the needs and experiences of women with Overt POI.
References
Sopiarz, N.; Sparzak, P.B. Primary Ovarian Insufficiency. In StatPearl; Treasure Island (FL): StatPearls Publishing: Amsterdam, The Netherlands, 2024. Available on: https://www.ncbi.nlm.nih.gov/books/NBK589674/ (accessed on 6 March 2023).
Stuenkel, C.A.; Gompel, A. Primary Ovarian Insufficiency. New England Journal of Medicine, 2023, 388(2): 154–163. PMID: 36630623. https://doi.org/10.1056/NEJMcp2116488. PMID: 36630623. DOI: https://doi.org/10.1056/NEJMcp2116488
Taruscio, D.; Gahl, W.A. Rare diseases: Challenges and opportunities for research and public health. Nature Reviews Disease Primers, 2024, 10(1): 13. PMID: 38424095. https://doi.org/10.1038/s41572-024-00505-1. DOI: https://doi.org/10.1038/s41572-024-00505-1
Nguengang Wakap, S.; Lambert, D.M.; Olry, A.; Rodwell, C.; Gueydan, C.; Lanneau, V.; Murphy, D.; Le Cam, Y.; Rath, A. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. European Journal of Human Genetics, 2020, 28(2): 165–173. PMID: 31527858; PMCID: PMC6974615. https://doi.org/10.1038/s41431-019-0508-0. DOI: https://doi.org/10.1038/s41431-019-0508-0
Gibbs, R. A. (2020). The Human Genome Project changed everything. Nature Reviews Genetics, 21(10), 575- 576. https://doi.org/10.1038/s41576-020-0275-3 DOI: https://doi.org/10.1038/s41576-020-0275-3
Tran, H., Yang, R., Fischer, K., Makris, M., & Konkle, B. A. (2024). The importance and evolution of bleeding disorder registries. Haemophilia. Advanced online publication. https://doi.org/10.1111/hae.14993 DOI: https://doi.org/10.1111/hae.14993
Perestelo-Pérez, L.; Rivero -Santana, A.; Abt-Sacks, A.; Toledo-Chavarri, A.; Brito, N.; Álvarez-Pérez, Y.; González -Hernández, N.; Serrano -Aguilar, P. Patient empowerment and involvement in research. Rare Diseases Epidemiology: Update and Overvie, 2017, 1031: 249–264). https://doi.org/10.1007/978-3-319- 67144-4_15. DOI: https://doi.org/10.1007/978-3-319-67144-4_15
Cooper, A.R.; Baker, V.L.; Sterling, E.W.; Ryan, M.E.; Woodruff, T.K.; Nelson, L.M. The time is now for a new approach to primary ovarian insufficiency. Fertility and Sterility, 2011, 95(6): 1890–1897. PMID: 20188353; PMCID: PMC2991394. https://doi.org/10.1016/j.fertnstert.2010.01.016. DOI: https://doi.org/10.1016/j.fertnstert.2010.01.016
Falorni, A.; Minarelli, V.; Eads, C.M.; Joachim, C.M.; Persani, L.; Rossetti, R.; Yurttas Beim, P.; Pellegrini, V.A.; Schnatz, P.F.; Rafique, S.; et al. A clinical research integration special program (CRISP) for young women with primary ovarian insufficiency. Panminerva Medica, 2014, 56(4): 245–261. PMID: 25288327; PMCID: PMC4532281.
Nelson, L. Primary Ovarian Insufficiency: A new paradigm for care and research. Research Features, 2024, 151. https://doi.org/10.26904/RF-151-6106349171 DOI: https://doi.org/10.26904/RF-151-6106349171
Nelson, L.M. A call for a US National Institute of Women’s Health and Human Development. Frontiers in Endocrinology, 2024, 15: 1289592. PMID: 38510700; PMCID: PMC10950976. https://doi.org/10.3389/fendo.2024.1289592. DOI: https://doi.org/10.3389/fendo.2024.1289592
Joachim, C.M.; Eads, C.M.; Persani, L.; Yurttas Beim, P.; Nelson, L.M. An open letter to the primary ovarian insufficiency community. Minerva Ginecologica, 2014, 66(5): 519–520. PMID: 25246000; PMCID: PMC4532280.
National Cancer Institute. NCI-Designated Cancer Centers. Available on: https://www.cancer.gov/research/infrastructure/cancer centers (accessed on 15 April 2024)
Shahzad, M.; Upshur, R.; Donnelly, P.; Bharmal, A.; Wei, X.; Feng, P.; Brown, A.D. A population-based approach to integrated healthcare delivery: a scoping review of clinical care and public health collaboration. BMC Public Health, 2019, 19(1): 708. PMID: 31174501; PMCID: PMC6556001. https://doi.org/10.1186/s12889-019-7002-z. DOI: https://doi.org/10.1186/s12889-019-7002-z
Silvén, H.; Savukoski, S.M.; Pesonen, P.; Pukkala, E.; Gissler, M.; Suvanto, E.; Niinimäki, M . Incidence and familial risk of premature ovarian insufficiency in the Finnish female population. Human Reproduction, 2022, 37(5): 1030–1036. PMID: 35134918; PMCID: PMC9071220. https://doi.org/10.1093/humrep/deac014. DOI: https://doi.org/10.1093/humrep/deac014
University of Washington Center for Mendelian Genetics. Available on: https://mygene2.org/MyGene2/ (accessed on 15 April 2024)
Philippakis, A.A.; Azzariti, D.R.; Beltran, S.; Brookes, A.J.; Brownstein, C.A.; Brudno, M.; Brunner, H.G.; Buske, O.J.; Carey, K.; Doll, C.; et al. The Matchmaker Exchange: A Platform for Rare Disease Gene Discovery. Human Mutation, 2015, 36: 915–921. https://doi.org/10.1002/humu.22858. DOI: https://doi.org/10.1002/humu.22858
Wohler, E.; Martin, R.; Griffith, S.; Rodrigues, E.D.S.; Antonescu, C.; Posey, J.E.; Coban-Akdemir, Z.; Jhangiani, S.N.; Doheny, K.F.; Lupski, J.R.; et al. PhenoDB, GeneMatcher and VariantMatcher, tools for analysis and sharing of sequence data. Orphanet Journal of Rare Diseases, 2021, 16(1): 365. PMID: 34407837; PMCID: PMC8371856. https://doi.org/10.1186/s13023-021-01916-z. DOI: https://doi.org/10.1186/s13023-021-01916-z
Wallace, S.S.; Barak, G.; Truong, G.; Parker, M.W. Hierarchy of Evidence Within the Medical Literature.
Hospital Pediatrics, 2022, 12(8): 745–750. PMID: 35909178. https://doi.org/10.1542/hpeds.2022-006690. DOI: https://doi.org/10.1542/hpeds.2022-006690
Nelson, L.M. The truth about 17-beta estradiol: menopause beyond “old wives’ tales”. Frontiers in Endocrinology, 202, 14: 1229804. PMID: 37766693; PMCID: PMC10520270. https://doi.org/10.3389/fendo.2023.1229804. DOI: https://doi.org/10.3389/fendo.2023.1229804
Nelson, L.M.; Spencer, H.; Hijane, K.; Thinuan, P.; Nelson, C.W.; Vincent, A.J.; Gordon, C.M.; Plant, T.M.; Fazeli, P.K. My 28 Days—A global digital women’s health initiative for evaluation and management of secondary amenorrhea: case report and literature review. Frontiers in Endocrinology, 2023, 14: 1227253. PMID: 37772077; PMCID: PMC10523024. https://doi.org/10.3389/fendo.2023.1227253. DOI: https://doi.org/10.3389/fendo.2023.1227253
My 28 Days. Available on: https://my28days.org/ (accessed on 15 April 2024).
Popat, V.B.; Calis, K.A.; Kalantaridou, S.N.; Vanderhoof, V.H.; Koziol, D.; Troendle, J.F.; Reynolds, J.C.; Nelson, L.M. Bone mineral density in young women with primary ovarian insufficiency: results of a three- year randomized controlled trial of physiological transdermal estradiol and testosterone replacement. The Journal of Clinical Endocrinology & Metabolism, 2014, 99(9): 3418–3426. PMID: 24905063; PMCID: PMC4154086. https://doi.org/10.1210/jc.2013-4145. DOI: https://doi.org/10.1210/jc.2013-4145
Hansen, K.R.; Knowlton, N.S.; Thyer, A.C.; Charleston, J.S.; Soules, M.R.; Klein, N.A. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Human Reproduction, 2008, 23(3): 699–708. PMID: 18192670. https://doi.org/10.1093/humrep/dem408. DOI: https://doi.org/10.1093/humrep/dem408
Rosen, M.P.; Johnstone, E.; McCulloch, C.E.; Schuh-Huerta, S.M.; Sternfeld, B.; Reijo-Pera, R.A.; Cedars,
M.I. A characterization of the relationship of ovarian reserve markers with age. Fertility and Sterility, 2012， 97(1): 238–243. PMID: 22130324; PMCID: PMC3312467. https://doi.org/10.1016/j.fertnstert.2011.10.031. DOI: https://doi.org/10.1016/j.fertnstert.2011.10.031
Piedade, K.C.; Spencer, H.; Persani, L.; Nelson, L.M. Optimizing Fertility in Primary Ovarian Insufficiency: Case Report and Literature Review. Frontiers in Genetics, 2021, 12: 676262. PMID: 34249096; PMCID: PMC8261244. https://doi.org/10.3389/fgene.2021.676262. DOI: https://doi.org/10.3389/fgene.2021.676262
McDonald, I.R.; Welt, C.K.; Dwyer, A.A. Health-related quality of life in women with primary ovarian insufficiency: a scoping review of the literature and implications for targeted interventions. Human Reproduction, 202, 37(12): 2817–2830. PMID: 36102839; PMCID: PMC9989734. https://doi.org/10.1093/humrep/deac200. DOI: https://doi.org/10.1093/humrep/deac200
Moukhah, S.; Ghorbani, B.; Behboodi-Moghadam, Z.; Zafardoust, S. Perceptions and experiences of women with premature ovarian insufficiency about sexual health and reproductive health. BMC Womens Health, 2021, 21(1): 54. PMID: 33557799; PMCID: PMC7869211. https://doi.org/10.1186/s12905-021-01197-5. DOI: https://doi.org/10.1186/s12905-021-01197-5
Primary Ovarian Insufficiency—A Peer-To-Peer Support. Available on: https://www.facebook.com/groups/31804248212 (accessed on 15 April 2024).
A Community Resource for Primary Ovarian Insufficiency (POI). Available on: https://www.facebook.com/groups/64513377304 (accessed on 15 April 2024).
Abdallah, S.; Sharifa, M.; Almadhoun, M.K.I.; Khawar, M.M.; Shaikh, U.; Balabel, K.M.; Saleh, I.; Manzoor, A.; Mandal, A.K.; Ekomwereren, O.; et al. The Impact of Artificial Intelligence on Optimizing Diagnosis and Treatment Plans for Rare Genetic Disorders. Cureus, 2023, 15(10): e46860. PMID: 37954711; PMCID: PMC10636514. https://doi.org/10.7759/cureus.46860. DOI: https://doi.org/10.7759/cureus.46860
Abdelhalim, H.; Berber, A.; Lodi, M.; Jain, R.; Nair, A.; Pappu, A.; Patel, K.; Venkat, V.; Venkatesan, C.; Wable, R.; et al. Artificial intelligence, healthcare, clinical genomics, and pharmacogenomics approaches in precision medicine. Frontiers in Genetics, 2022, 13: 929736. https://doi.org/10.3389/fgene.2022.929736. DOI: https://doi.org/10.3389/fgene.2022.929736
Gundersen, T.; Bærøe, K . The Future Ethics of Artificial Intelligence in Medicine: Making Sense of Collaborative Models. Science and Engineering Ethics, 2022, 28(2): 17. PMID: 35362822; PMCID: PMC8975759. https://doi.org/10.1007/s11948-022-00369-2. DOI: https://doi.org/10.1007/s11948-022-00369-2
Carpenter, J.S.; Cortés, Y.I.; Tisdale, J.E.; Sheng, Y.; Jackson, E.A.; Barinas-Mitchell, E.; Thurston, R.C. Palpitations across the menopause transition in SWAN: trajectories, characteristics, and associations with subclinical cardiovascular disease. Menopause, 2023, 30(1): 18–27. PMID: 36256921; PMCID: PMC9797427. https://doi.org/10.1097/GME.0000000000002082. DOI: https://doi.org/10.1097/GME.0000000000002082
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Karima Hijane, Lawrence M. Nelson
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommerical-NoDerivatives 4.0 International License.
